News

John Perfect, MD, professor of medicine and chief of the Division of Infectious Diseases, received notification today from the National Institute of Allergy and Infectious Diseases of a program project award (P01) for his proposal entitled “Transdisciplinary Program to Identify Novel Antifungal Targets and Inhibitors."  This award, effective 6/25/15, will last five years and, with its cores, total $9,277,000.

Ricky Bloomfield, MD, assistant professor of internal medicine (pediatrics) and director of mobile technology strategy for

Karen Goldstein, MD, MSPH, has just receive

Will Yancy, MD, MHS, associate professor of medicine (General Inte

Eric Peterson, MD, professor of medicine and executive director of the Duke Clinical Research Institute, was quoted in the New York Times in a front-page story about the nationwide quality movement in the management of acute myocardial infarction.

From the Director

Patients with atrial fibrillation who stopped taking blood thinners before they had elective surgery had no higher risk of developing blood clots and less risk of major bleeding compared to patient

The Duke Human Vaccine Institute’s Vaccine and Treatment Evaluation Unit has been awarded a $5 million contract from the National Institute of Allergy and Infect

New research from a team including lead author William Yancy, MD (left), as well a